Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/UR8 stock hub

FRA/UR8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/UR8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/UR8FRA/UR8

—

Loading chart…

In the news

Latest news · FRA/UR8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-88.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/UR8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	DE
Employees	291
Employees Change	70%
Employees Change Percent	32.26
Enterprise value	EUR 1.3B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.2B
Price	EUR 25.2
Price currency	EUR
Rev Per Employee	408,891.2x
Sic	2836
Symbol	fra/UR8
Website	https://www.urogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.49%
EV Earnings	-10.95x
EV/FCF	-8.79x
EV/Sales	10.6x
FCF yield	-11.83%
P/B ratio	-11.29x
P/S ratio	9.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-77.02%
EBITDA Margin	-76.8%
Gross margin	89.85%
Gross Profit	EUR 109.5M
Gross Profit Growth	53.22%
Gross Profit Growth Q	161.21%
Gross Profit Growth3 Y	28.43%
Gross Profit Growth5 Y	48.67%
Net Income	EUR -115.5M
Pretax Margin	-98.45%
Profit Margin	-94.83%
Profit Per Employee	EUR -387,738
ROA	-26.98
Roa5y	-34.08
ROCE	-53.29
ROIC	-88.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	54.65%
Cagr3y	32.22%
Cagr5y	11.54%
Revenue Growth	52.92x
Revenue Growth Q	151.6x
Revenue Growth3 Y	27.37x
Revenue Growth5 Y	48.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.56
Assets	EUR 220M
Cash	EUR 121.7M
Current Assets	EUR 201.4M
Current Liabilities	EUR 42.9M
Debt	EUR 170.9M
Debt FCF	EUR -1.19
Equity	EUR -107.8M
Interest Coverage	-7
Liabilities	EUR 327.8M
Long Term Assets	EUR 18.7M
Long Term Liabilities	EUR 284.9M
Net Cash	EUR -49.3M
Net Cash By Market Cap	EUR -4.05
Tangible Book Value	EUR -107.8M
Tangible Book Value Per Share	EUR -2.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.69
Inventory Turnover	1
Net Working Capital	EUR 42M
Quick ratio	3.86
Working Capital	EUR 162M
Working Capital Turnover	EUR 0.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	54.6%
200-day SMA	17.27
3Y total return	131.19%
50-day SMA	17.45
50-day SMA vs 200-day SMA	50over200
5Y total return	72.6%
All Time High	55.46
All Time High Change	-54.56%
All Time High Date	2019-01-08
All Time Low	3.32
All Time Low Change	659.04%
All Time Low Date	2025-05-28
ATR	0.93
Ch YTD	30.57
High	25.66
High52	25.66
High52 Date	2026-05-08
High52ch	-1.79%
Low	22.13
Low52	3.32
Low52 Date	2025-05-28
Low52ch	659.04%
Ma50ch	44.41%
Price vs 200-day SMA	45.9%
RSI	77.29
RSI Monthly	60.47
RSI Weekly	70.59
Sharpe ratio	1.42x
Sortino ratio	2.35
Total Return	-7.34%
Tr YTD	30.57
Tr1m	60.31%
Tr1w	31.63%
Tr3m	48.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -93.9M
Operating margin	-77.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,698,096%
Net Borrowing	53,565,759.5
Shares Insiders	2.06%
Shares Institutions	78.75%
Shares Qo Q	1.93%
Shares Yo Y	7.34%
Short Ratio	9.11

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -155.7M
Average Volume	20.15x
Bv Per Share	-2.21
CAPEX	EUR -259,323
Ch1m	60.31
Ch1w	31.63
Ch1y	54.6
Ch3m	48.24
Ch3y	131.2
Ch5y	72.6
Ch6m	29.23
Change	10.09%
Change From Open	13.87
Close	22.89
Days Gap	-3.32
Depreciation Amortization	262,868.2
Dollar Volume	7,635.6
Earnings Date	2026-05-06
EBIT	EUR -93.9M
EBITDA	EUR -93.6M
EPS	EUR -2.37
F Score	2
FCF	EUR -144M
FCF EV Yield	-11.38x
Financing CF	91,142,822
Fiscal Year End	December
Founded	2,004
Income Tax	EUR -4.4M
Investing CF	57,964,261
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	17.73
Ma150ch	42.14%
Ma20	19.65
Ma20ch	28.22%
Net CF	5,364,251
Next Earnings Date	2026-05-11
Open	22.13
Position In Range	86.97
Ppne	7,255,162.9
Price Date	2026-05-08
Relative Volume	15.04x
Revenue	121,849,579x
SBC By Revenue	9.62x
Share Based Comp	11,723,294
Tax By Revenue	-3.62x
Tr6m	29.23%
Volume	303
Z Score	-4.11

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/UR8 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/UR8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/UR8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+78.7%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/UR8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

77.3

Above 70: short-term overbought

Price vs 200-day MA

+45.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/UR8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/UR8 stock rating?

fra/UR8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/UR8 analysis?

The full report lives at /stocks/fra/UR8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/UR8?

The latest report frames fra/UR8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/UR8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.